Fig 10 - by Naveed Arshad (19712985)

Subjects:

The technical route of the study. by Hongliang Zou (20707270)

Subjects:

Point cloud fusion instance effect. by Hongliang Zou (20707270)

Subjects:

Experimental results in the SubT-MRS dataset. by Hongliang Zou (20707270)

Subjects:

Results of physiological parameters. by Vanessa Wellauer (18408477)

Subjects:

In vivo combination activity of AMG 510 and pemigatinib in epithelial-like or mesenchymal-like phenotype lung cancer PDX models. by Angela Abdollahi (15166230)

Fig 1 - by Farshid Maleki (20521649)

Subjects:

Fig 5 - by Farshid Maleki (20521649)

Subjects:

Fig 3 - by Yong-Rae Kim (19797278)

Subjects:

Fig 4 - by Yong-Rae Kim (19797278)

Subjects:

Fig 5 - by Yong-Rae Kim (19797278)

Subjects:

Comparison of six theoretical mood factors and TMD scores estimated using K-POMS-B between three ECDs (<i>n</i> = 34; *<i>p</i> < 0.05 using Friedman test with Bonferroni’s correct... by Yong-Rae Kim (19797278)

Subjects:

Rate of apoptosis in MDA-MB-231 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). by Farshid Maleki (20521649)

Subjects:

Rate of apoptosis in MCF-7 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). by Farshid Maleki (20521649)

Subjects:

DDC for four anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

Isotype control overlays. by Chen Lu (135200)

Subjects:

Original uncropped blot. by Chen Lu (135200)

Subjects:

Raw Data. by Chen Lu (135200)

Subjects:

Identification of BM-MSCs. by Chen Lu (135200)

Subjects:

Inpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects: